Determining the Risk of Stress Fracture in IDF Soldiers Based on SNPs Identified for Osteoporosis
NCT ID: NCT03197545
Last Updated: 2017-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
440 participants
OBSERVATIONAL
2017-06-30
2020-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bone Geometry, Strength, and Biomechanical Changes in Runners With a History of Stress Fractures
NCT00766077
Determining the Risk Factors Such as Smoking, Alcohol, and Caffeine and Their Association With Osteoporosis in Men
NCT00011323
The Impact of Hormonal Contraceptive Use and Lifestyle Factors on Fracture Risk and Bone Quality in Young Female Adults
NCT06608862
Radiological Biological Genetic and Micro-architectural Bone Determinants of Fractures in Men With Low Bone Mineral Density
NCT01250314
Evaluation and Intervention for the Effects of Osteogenesis Imperfecta
NCT00001594
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We will examine the presence or absence of 96 SNPs - 76 SNPs that were previously validated as significant with low BMD or Osteoporosis and 20 SNPs offered for Stress Fractures with recruits who were diagnosed with Stress Fractures during basic training (basic training lasts four months - six months) using SNP Genotyping Analysis-TaqMan Assays. The buccal swab will be taken from recruits who served for at least four months and up to six months in the IDF - Infantry Corps. Buccal swabs will be taken at a single meeting from recruits serving between 4 and 6 months in the IDF - Infantry Corps, which will be used to compare using SNP Genotyping Analysis-TaqMan Assays with the SNPs listed above. In addition, in this single meeting, the recruits will fill out a questionnaire in which they will be asked whether they experienced traumatic fracture from their youth to the time of filling the questionnaire (recruits who experienced traumatic fractures but are not diagnosed with stress fractures constitute as a control group in the research).
There will be one meeting with recruiters who served for at least four months and up to six months in the IDF - infantry. At this meeting, the recruits will be sampled with a buccal swab and fill out a questionnaire.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stress fracture group
110 recruits diagnosed (clinicaly and/or by imaging) with at least one stress fracture, during basic and advanced infantry trainig.
No interventions assigned to this group
Traumatic fracture group
110 infantry recruits with medical history of having at least one traumatic fracture, during their life (from birth up to date).
No interventions assigned to this group
Control group
220 healthy infantry recruits never diagnosed with stress fracture or traumatic fractures
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All participants (440) are recruits who serve 4-6 months in the IDF - infantry - basic training.
* 110 recruits with a stress fracture diagnosis in their medical portfolio.
* 110 recruits who have Section 4161x flaw (section Eclipse: a long bone fracture)
* 220 recruits without the aforementioned impairment clause and the above mentioned diagnosis (referred as control group).
Exclusion Criteria
* A recruiter who did not complete his training due to a course that lasted over two weeks while carrying out basic training.
* A recruiter who did not complete his basic training due to absenteeism.
* A recruiter who has not completed his basic training due to problems with the service conditions.
* A recruiter who has not completed his basic training due to the reduction of a medical profile.
* A recruiter who did not complete his basic training due to a decrease in the recruitment cycle.
18 Years
25 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bar-Ilan University, Israel
OTHER
Medical Corps, Israel Defense Force
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
YEHUDA DAVID
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Izhak Haviv, Prof.
Role: STUDY_CHAIR
Bar-Ilan Faculty of Medicine, Safed
David Karasik, Prof.
Role: STUDY_DIRECTOR
Bar-Ilan Faculty of Medicine, Safed
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bar Ilan University
Safed, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1579-2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.